West Pharmaceutical Services Shares Outstanding 2010-2024 | WST

West Pharmaceutical Services shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • West Pharmaceutical Services shares outstanding for the quarter ending September 30, 2024 were 0.073B, a 2.52% decline year-over-year.
  • West Pharmaceutical Services 2023 shares outstanding were 0.075B, a 0.66% decline from 2022.
  • West Pharmaceutical Services 2022 shares outstanding were 0.076B, a 0.66% decline from 2021.
  • West Pharmaceutical Services 2021 shares outstanding were 0.076B, a 0.66% increase from 2020.
West Pharmaceutical Services Annual Shares Outstanding
(Millions of Shares)
2023 75
2022 76
2021 76
2020 76
2019 75
2018 75
2017 76
2016 75
2015 74
2014 73
2013 71
2012 72
2011 74
2010 73
2009 73
West Pharmaceutical Services Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 73
2024-06-30 74
2024-03-31 74
2023-12-31 75
2023-09-30 75
2023-06-30 75
2023-03-31 76
2022-12-31 76
2022-09-30 76
2022-06-30 76
2022-03-31 76
2021-12-31 76
2021-09-30 76
2021-06-30 76
2021-03-31 76
2020-12-31 76
2020-09-30 76
2020-06-30 76
2020-03-31 76
2019-12-31 75
2019-09-30 76
2019-06-30 75
2019-03-31 75
2018-12-31 75
2018-09-30 76
2018-06-30 75
2018-03-31 76
2017-12-31 76
2017-09-30 76
2017-06-30 76
2017-03-31 75
2016-12-31 75
2016-09-30 75
2016-06-30 75
2016-03-31 74
2015-12-31 74
2015-09-30 74
2015-06-30 74
2015-03-31 73
2014-12-31 73
2014-09-30 73
2014-06-30 72
2014-03-31 72
2013-12-31 71
2013-09-30 71
2013-06-30 71
2013-03-31 70
2012-12-31 72
2012-09-30 69
2012-06-30 73
2012-03-31 74
2011-12-31 74
2011-09-30 74
2011-06-30 74
2011-03-31 74
2010-12-31 73
2010-09-30 73
2010-06-30 73
2010-03-31 73
2009-12-31 73
2009-09-30 73
2009-06-30 72
2009-03-31 72
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.592B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
Straumann Holding AG (SAUHY) Switzerland $23.137B 0.00
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09